The past week has been none too kind to the PowerShares QQQ (NASDAQ: QQQ), also known as the NASDAQ 100 tracking ETF. QQQ has tumbled 4.1%, but let's remember that the fund is up 15.4% year-to-date and the Nasdaq is the best performing of the major U.S. indexes.

Of course, much of the good fortune for QQQ and the Nasdaq Composite this year is attributable to the meteoric rise of Apple (NASDAQ: AAPL), but even shares of the iPad and iPhone maker have had a tough go of things in recent weeks, sliding 9.4% in the past month.

With that pullback, there are now a few Nasdaq constituents that have actually outperformed Apple on a year-to-date basis. Let's have a look at few Nasdaq names that are in Apple's league or even beating the tech juggernaut this year.

Lululemon Atheltica (NASDAQ: LULU):

Shares of Lululemon have surged nearly 59% year-to-date, but some of the wind has come out of the stock's sails recently as the shares have tumbled nearly 7% in the past week. Still, 59% in less than five months is impressive and it proves consumers are willing to pay up for Lululemon's pricy workout attire.

However, there are some some issues that might prove concerning. First, most of Lululemon's customers are women, but the company is looking to gain affinity among men. Most analysts that follow the company don't even realize how hard it's going to be to get most regular guys to spend up for Lululemon's apparel.

Second, Lululemon trades at almost 36 times forward earnings. Apple doesn't even have a forward P/E of 11. Any earnings misstep by Lululemon would lead to harsh selling pressure. (NASDAQ: PCLN):

Priceline was up 54% year-to-date when the market closed on Wednesday. That number is likely to be smaller by the time the market closes on Thursday following some concerning second-quarter guidance from the online travel reservations firm.

Priceline expects to earn $7.20 to $7.40 a share, excluding special charges, on an 18% to 23% revenue gain. Analysts expect a sales jump of 26.4%. The midpoint of the company's profit estimate is $7.30, less than the $7.38 forecast by analysts, according to Investor's Business Daily. That was enough to send the shares down more than 3% in after-hours trading.

Vertex Pharmaceuticals (NASDAQ: VRTX):

Vertex accounts for less than half of a percent of the Nasdaq 100's weight, but its performance has been huge recently. In the past week alone share of the biotech firm have soared more than 57% after the company announced positive trial results for its two-drug treatment for cystic fibrosis. Kalydeco along with an experimental drug, VX-809, showed improved breathing in patients participating in the trial.

This is good news not only for Vertex shareholders, but the patients as well because cystic fibrosis is currently incurable and kills most that suffer from it before they turn 40.

Related Articles
  1. Chart Advisor

    Bumpy Roads Ahead In Transportation

    Investors are keeping an eye on the transportation industry. We'll take a look at the trend direction and how to trade it.
  2. Investing

    How ETFs May Save You Thousands

    Being vigilant about the amount you pay and what you get for is important, but adding ETFs into the investment mix fits well with a value-seeking nature.
  3. Mutual Funds & ETFs

    3 Fixed Income ETFs in the Mining Sector

    Learn about the top three metals and mining exchange-traded funds (ETFs), and explore analyses of their characteristics and how investors can benefit from these ETFs.
  4. Chart Advisor

    Agriculture Commodities Are In The Bear's Sights

    Agriculture stocks have experienced strong moves higher over recent weeks, but chart patterns on sugar, corn and wheat are suggesting the moves could be short lived.
  5. Investing News

    Top Tips for Diversifying with Mutual Funds

    Are mutual funds becoming obsolete? If they have something to offer, which funds should you consider for diversification?
  6. Professionals

    Top Stocks to Short, Go Long On to Beat the Market

    A long/short portfolio can help weather a variety of market scenarios. Here's how to put one together.
  7. Mutual Funds & ETFs

    Top 4 Asia-Pacific ETFs

    Learn about four of the best-performing exchange-traded funds, or ETFs, that offer investors exposure to the Asia-Pacific region.
  8. Stock Analysis

    The Biggest Oil Producers in Asia

    Learn which Asian countries deliver the most crude oil to market, and discover what companies are the biggest producers in each country.
  9. Mutual Funds & ETFs

    Top 3 Japanese Bond ETFs

    Learn about the top three exchange-traded funds (ETFs) that invest in sovereign and corporate bonds issued by developed countries, including Japan.
  10. Stock Analysis

    The 5 Biggest Russian Oil Companies

    Discover the top Russian oil companies by production volume and find out more about their domestic and international business operations.
  1. Can mutual funds invest in IPOs?

    Mutual funds can invest in initial public offerings (IPOS). However, most mutual funds have bylaws that prevent them from ... Read Full Answer >>
  2. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  3. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  4. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  5. Does index trading increase market vulnerability?

    The rise of index trading may increase the overall vulnerability of the stock market due to increased correlations between ... Read Full Answer >>
  6. What does a high turnover ratio signify for an investment fund?

    If an investment fund has a high turnover ratio, it indicates it replaces most or all of its holdings over a one-year period. ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!